Free Helpline
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Understanding Ocrevus (ocrelizumab) dosage is key for MS patients. This guide explains starter and maintenance infusions, administration, and what to do if you miss a dose.
Navigating treatment for conditions like Multiple Sclerosis (MS) can feel overwhelming, and understanding your medication is a vital part of the journey. Ocrevus, known scientifically as ocrelizumab, is a significant treatment option for adults with relapsing forms of MS and clinically isolated syndrome. This powerful biologic drug, a type of monoclonal antibody, works by targeting specific immune cells that contribute to MS progression. For patients in India and around the globe, grasping the nuances of Ocrevus dosage is essential for effective treatment and managing expectations. This guide aims to demystify the Ocrevus dosage regimen, from the initial starter doses to the ongoing maintenance infusions, providing clear, practical information tailored for you.
Ocrevus is not a daily pill; it's administered as an intravenous (IV) infusion, meaning it's given directly into your vein over a period of time. This method ensures the medication enters your bloodstream effectively. As a biologic drug, Ocrevus is derived from living organisms and is designed to precisely target certain cells within your immune system. Specifically, it targets B cells, a type of white blood cell that plays a role in the inflammatory processes associated with MS. By reducing the number of these B cells, Ocrevus helps to lessen the inflammation and damage to nerve cells that characterize MS. This targeted approach aims to slow disease progression and reduce the frequency of relapses.
The Ocrevus treatment plan is structured to allow your doctor to monitor your body's response and ensure optimal effectiveness and safety. It typically involves two distinct phases: the initial starter doses and the long-term maintenance doses.
Your Ocrevus journey begins with two initial infusions, administered a few weeks apart. This introductory phase is designed for careful observation. The standard starting dosage is:
These initial doses are intentionally lower than the maintenance doses. This allows your healthcare team to assess how your body tolerates the medication. It’s a period of close monitoring to identify any potential immediate reactions and to ensure the treatment is a suitable option for you. Your doctor will closely watch for any signs of infusion-related reactions during this time.
Once the initial phase is successfully completed, your Ocrevus treatment transitions to a maintenance schedule. This is where the dosage increases to ensure sustained therapeutic effect:
These maintenance infusions are typically longer, lasting between 2 to 3.5 hours, and sometimes longer, especially if any infusion-related reactions occurred previously. The goal of this every-six-month schedule is to maintain a consistent level of the medication in your system, providing ongoing protection against disease activity.
Ocrevus comes in a specific strength to ensure accurate dosing. It is available as a solution with a concentration of 300 milligrams (mg) of ocrelizumab in 10 milliliters (mL) of solution, which can also be expressed as 30 mg/mL. This concentration is carefully prepared for IV infusion.
The administration itself is a medical procedure. A trained healthcare professional will administer the Ocrevus infusion. You will typically receive your infusions at:
In some cases, depending on your insurance coverage and local healthcare policies in India, home infusions might be an option. Discuss this possibility with your doctor and insurance provider. The infusion process requires monitoring, so it's important to be in a setting where medical staff are readily available.
Missing a scheduled Ocrevus infusion can happen, but it's important to act quickly. If you miss an appointment, contact your doctor's office or infusion center immediately. Do not wait for your next scheduled dose.
The most important step is communication. Always inform your healthcare provider about any missed appointments so they can guide you on the next steps and adjust your treatment plan accordingly.
Like all medications, Ocrevus can cause side effects. The most common concerns revolve around infusion-related reactions. These can occur during or shortly after the infusion and may include:
If you experience any of these symptoms during your infusion, the healthcare professional administering it will likely slow down the infusion rate, temporarily stop it, or manage the symptoms with other medications. In some cases, they might need to stop Ocrevus treatment altogether if the reactions are severe. It is vital to report any unusual sensations or symptoms to your medical team immediately.
Other potential side effects, though less common, can include increased risk of infections, particularly upper respiratory tract infections. Your doctor will monitor you for these and may recommend preventive measures.
Ocrevus is generally considered a long-term treatment option for MS and clinically isolated syndrome. If you and your doctor agree that the medication is effective and well-tolerated, you will likely continue treatment for an extended period. This ongoing commitment is part of managing a chronic condition like MS effectively. Regular check-ups and open communication with your neurologist are paramount to ensuring the treatment remains beneficial throughout your journey.
It is essential to maintain a strong relationship with your healthcare provider. Schedule regular appointments as recommended by your doctor. You should contact your doctor immediately if:
Your doctor is your primary resource for managing your Ocrevus therapy and your overall health. Don't hesitate to reach out with any questions or concerns, no matter how small they may seem.
A1: No, Ocrevus is not an oral medication. It is administered exclusively as an intravenous (IV) infusion by a healthcare professional.
A2: After the initial starter doses, you will receive a 600 mg infusion every 6 months. Your doctor will confirm your specific schedule.
A3: The starter doses are two 300 mg infusions given 2 weeks apart to assess tolerance. The maintenance dose is a higher 600 mg infusion given every 6 months for ongoing treatment.
A4: In some cases, home infusions may be possible, depending on your insurance provider and local healthcare regulations. Discuss this option with your doctor.
A5: If you experience a reaction, the healthcare provider will manage it, which may involve slowing or stopping the infusion. Report any symptoms immediately.
Disclaimer: This information is intended for educational purposes and should not replace professional medical advice. Always consult with your doctor or healthcare provider for any health concerns or before making any decisions related to your treatment.
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026
Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026